These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 17239354

  • 41. Effect of cannabidiol on muscarinic neurotransmission in the pre-frontal cortex and hippocampus of the poly I:C rat model of schizophrenia.
    Jimenez Naranjo C, Osborne AL, Weston-Green K.
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug 30; 94():109640. PubMed ID: 31108177
    [Abstract] [Full Text] [Related]

  • 42. Identification of M(1) muscarinic receptor subtype in rat stomach using a tissue segment binding method, and the effects of immobilization stress on the muscarinic receptors.
    Anisuzzaman AS, Morishima S, Suzuki F, Tanaka T, Muramatsu I.
    Eur J Pharmacol; 2008 Dec 03; 599(1-3):146-51. PubMed ID: 18938154
    [Abstract] [Full Text] [Related]

  • 43. Changes in cholinergic and glutamatergic markers in the striatum from a sub-set of subjects with schizophrenia.
    Dean B, Thomas N, Lai CY, Chen WJ, Scarr E.
    Schizophr Res; 2015 Dec 03; 169(1-3):83-88. PubMed ID: 26545297
    [Abstract] [Full Text] [Related]

  • 44. An investigation of the factors that regulate muscarinic receptor expression in schizophrenia.
    Seo MS, Scarr E, Dean B.
    Schizophr Res; 2014 Sep 03; 158(1-3):247-54. PubMed ID: 25037527
    [Abstract] [Full Text] [Related]

  • 45. Age-related changes of muscarinic cholinergic receptor subtypes in the striatum of Fisher 344 rats.
    Tayebati SK, Di Tullio MA, Amenta F.
    Exp Gerontol; 2004 Feb 03; 39(2):217-23. PubMed ID: 15036415
    [Abstract] [Full Text] [Related]

  • 46. Simvastatin reverses the downregulation of M1/4 receptor binding in 6-hydroxydopamine-induced parkinsonian rats: the association with improvements in long-term memory.
    Wang Q, Wei X, Gao H, Li J, Liao J, Liu X, Qin B, Yu Y, Deng C, Tang B, Huang XF.
    Neuroscience; 2014 May 16; 267():57-66. PubMed ID: 24613723
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Visualization of muscarinic receptor-mediated phosphoinositide turnover in the hippocampus of young and aged, learning-impaired Long Evans rats.
    Nicolle MM, Gallagher M, McKinney M.
    Hippocampus; 2001 May 16; 11(6):741-6. PubMed ID: 11811668
    [Abstract] [Full Text] [Related]

  • 50. Chronic treatment with simvastatin upregulates muscarinic M1/4 receptor binding in the rat brain.
    Wang Q, Zengin A, Ying W, Newell KA, Wang P, Yeo W, Wong PT, Yenari MA, Huang XF.
    Neuroscience; 2008 Jun 26; 154(3):1100-6. PubMed ID: 18501522
    [Abstract] [Full Text] [Related]

  • 51. Decreased phorbol ester binding in the parahippocampal gyrus from subjects with schizophrenia is not associated with changes in protein kinase C.
    Scarr E, Pavey G, Robinson PJ, Opeskin K, Copolov DL, Dean B.
    Mol Psychiatry; 2002 Jun 26; 7(7):683-8. PubMed ID: 12192611
    [Abstract] [Full Text] [Related]

  • 52. The effects of mercury on muscarinic cholinergic receptor subtypes (M1 and M2) in captive mink.
    Basu N, Scheuhammer AM, Rouvinen-Watt K, Evans RD, Grochowina N, Chan LH.
    Neurotoxicology; 2008 Mar 26; 29(2):328-34. PubMed ID: 18295336
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Muscarinic toxin selective for m4 receptors impairs memory in the rat.
    Jerusalinsky D, Kornisiuk E, Alfaro P, Quillfeldt J, Alonso M, Verde ER, Cerveñansky C, Harvey A.
    Neuroreport; 1998 May 11; 9(7):1407-11. PubMed ID: 9631438
    [Abstract] [Full Text] [Related]

  • 55. Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease.
    Tsang SW, Pomakian J, Marshall GA, Vinters HV, Cummings JL, Chen CP, Wong PT, Lai MK.
    Neurobiol Aging; 2007 Sep 11; 28(9):1381-7. PubMed ID: 16828202
    [Abstract] [Full Text] [Related]

  • 56. Immunoreactivity of 43 kDa growth-associated protein is decreased in post mortem hippocampus of bipolar disorder and schizophrenia.
    Tian SY, Wang JF, Bezchlibnyk YB, Young LT.
    Neurosci Lett; 2007 Jan 10; 411(2):123-7. PubMed ID: 17095155
    [Abstract] [Full Text] [Related]

  • 57. Changes in muscarinic acetylcholine receptor expression in form deprivation myopia in guinea pigs.
    Liu Q, Wu J, Wang X, Zeng J.
    Mol Vis; 2007 Jul 20; 13():1234-44. PubMed ID: 17679952
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Elevated levels of autoantibodies targeting the M1 muscarinic acetylcholine receptor and neurofilament medium in sera from subgroups of patients with schizophrenia.
    Jones AL, Mowry BJ, McLean DE, Mantzioris BX, Pender MP, Greer JM.
    J Neuroimmunol; 2014 Apr 15; 269(1-2):68-75. PubMed ID: 24636402
    [Abstract] [Full Text] [Related]

  • 60. Loss of muscarinic M4 receptors in hippocampus of Alzheimer patients.
    Mulugeta E, Karlsson E, Islam A, Kalaria R, Mangat H, Winblad B, Adem A.
    Brain Res; 2003 Jan 17; 960(1-2):259-62. PubMed ID: 12505680
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.